Ruth Ganss

Prof. Ruth Ganss


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Cancer Cell
Verified
Journal Article
Closed access
RDRose Du
Rose Du
KLKan V. Lu
Kan V. Lu
CPClaudia Petritsch
Claudia Petritsch
PLPatty Liu
Patty Liu
RGRuth Ganss
Ruth Ganss
GBGabriele Bergers
Gabriele Bergers

16 April 2008 in Nature
Verified
Journal Article
Closed access
JHJuliana Hamzah
Juliana Hamzah
MJManfred Jugold
Manfred Jugold
Fabian KiesslingFabian Kiessling
Fabian Kiessling
PRPaul Rigby
Paul Rigby
MMMitali Manzur
Mitali Manzur
RGRuth Ganss
Ruth Ganss

7 June 1994 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
EHE Hummler
E Hummler
TCT J Cole
T J Cole
JBJ A Blendy
J A Blendy
RGRuth Ganss
Ruth Ganss
AAA Aguzzi
A Aguzzi
GSG Schütz
G Schütz
The cAMP response element binding protein (CREB) has been implicated as a key regulator in the transcriptional control of many genes. To assess the functional importance of CREB in vivo and its role in development, we used gene targeting to generate mice with a disruption of the CREB gene. Homozygous mutant mice appeared healthy and exhibited no impairment of growth or development. In this report we demonstrate that CREB and two other members of the CREB/ATF family, cAMP response element modulation protein (CREM) and activating transcription factor 1 (ATF1), appear to form a unique subgroup within this extensive class of transcription factors. Examination of CREM mRNA and protein levels in CREB mutant mice demonstrated overexpression of CREM in all tissues examined, but no change in ATF1 levels. These data demonstrate that CREB is not the sole mediator of cAMP-dependent transcriptional regulation and probably acts in concert with a specific subset of cAMP response element-binding proteins to transduce the cAMP signal and, in its absence, these same proteins can compensate for CREB function in vivo.

11 September 2017 in Nature Immunology
Verified
Journal Article
Closed access
AJAnna Johansson-Percival
Anna Johansson-Percival
BHBo He
Bo He
ZLZhi-Jie Li
Zhi-Jie Li
AKAlva Kjellén
Alva Kjellén
KRKaren Russell
Karen Russell
RGRuth Ganss
Ruth Ganss

15 February 2006 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
KSK Schledzewski
K Schledzewski
MFM Falkowski
M Falkowski
GMG Moldenhauer
G Moldenhauer
PMP Metharom
P Metharom
JKJ Kzhyshkowska
J Kzhyshkowska
SGS Goerdt
S Goerdt

2 December 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
HSHerbert Spring
Herbert Spring
TSThomas Schüler
Thomas Schüler
BABernd Arnold
Bernd Arnold
GHGünter J. Hämmerling
Günter J. Hämmerling
RGRuth Ganss
Ruth Ganss
Tumor neovasculature substantially derives from sprouting of existing vessels, whereas the functional contribution of bone marrow-derived progenitors to neovessels remains controversial. We used transgenic mouse models of multistep carcinogenesis to monitor incorporation of bone marrow-derived cells into the neovasculature and to elucidate mechanisms of endothelial precursor cell (EPC) recruitment into the tumor microenvironment. We unequivocally demonstrate integration of bone marrow cells into the tumor vasculature as a late event in carcinogenesis that temporally correlates with VEGF release by the tumor and mobilization of circulating EPC in the periphery. Moreover, we demonstrate a chemokine-dependent mechanism of EPC homing into tumor, whereby neovessels of late-stage tumors release a battery of CC chemokines, which direct CCR2+and CCR5+progenitors into the vasculature. Thus, we show that tumor vessels promote their own growth and development in a self-amplifying fashion.